Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

By Palhagen S.   Canger R.   Henriksen O.   van Parys J.A.   Riviere M.-E.   Karolchyk M.A.  

Epilepsy Research, Vol. 43, Iss. 2, 2001-02 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

Does modafinil enhance activity of patients with myotonic dystrophy?: A double-blind placebo-controlled crossover study

By Wintzen A.R.   Lammers G.J.   Dijk J.G.  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 26-28

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

Evaluation of Gabapentin in an Outpatient and Office-based Sample of Epilepsy Patients - Two double-blind, placebo controlled studies

By Harden C.L.   Hosain S.   Nikolov B.   Labar D.R.  

Journal of Epilepsy, Vol. 11, Iss. 3, 1998-05 ,pp. : 130-135

Elsevier

Access to resources Recommend Favorite